College of Charleston
BMS - WW & US Oncology Medical Strategy
College of Charleston, Lawrenceville, New Jersey, United States,
POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP
– Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and Bristol Myers Squibb. Program emphasis is in
WW & US Oncology Medical Strategy . This 2-year Fellowship provides a unique opportunity to support the development and execution of Worldwide and US Oncology Medical Strategy and other medical activities. During the first year in Worldwide Medical Oncology, the Fellow will focus on developing the global strategy for new indications in a wide array of tumor types through collaborative efforts with BMS regional offices around the world. During the second year in US Medical Oncology, the Fellow will focus on developing and executing the US strategy for the successful launch and continued support of a wide range of indications through medical engagements, conferences, and launches. The Fellow will gain exposure to various stakeholders and develop leadership skills by supporting and leading medical initiatives in collaboration with the Worldwide and US cross-functional matrix teams (e.g., Clinical Development, Clinical Operations, Regulatory, Publications and Scientific Content, Field Medical, Commercial, HEOR, Competitive Intelligence, Access and more). Additionally, the Fellow will have opportunities to collaborate closely with the patient advocacy team, including partnering to present and execute patient advocacy advisory boards, attending patient advocacy meetings at congresses, and developing various patient-related tactics. This will provide the Fellow with a deep understanding of how our work directly impacts patients’ lives.WORLDWIDE MEDICAL STRATEGYGain experience in the development of a strategically-aligned Global Medical Plan based upon unmet medical need by collaborating with a cross-functional, multi-regional (i.e., US, EU, Asia-Pacific) Worldwide Medical matrix team.Engage with external Thought Leaders in an effort to exchange and gather scientific and clinical knowledge through investigator meetings, advisory boards, Thought Leader Engagements (TLEs), publication planning, and congresses.Lead the execution of medical deliverables that are closely aligned with the strategic Global Medical Plan, including National and International Congress planning for activities such as advisory boards, symposia, and TLEs.Collaborate with BMS country-specific medical colleagues to collect field insights that will support strategic planning and tactical execution.Actively participate in the review and approval process of Investigator Sponsored Research proposals that are aligned with the data generation plan detailed in the Global Medical Plan.US MEDICAL STRATEGYParticipate in key medical activities such as medical advisory boards, Field Medical resources and trainings, Congress planning (e.g., ASCO, ASCO GI), reactive content, and the communication strategy, including publications.Collaborate with US Medical matrix teams (e.g., Field Medical, Evidence Generation, Patient Advocacy, Medical Education, and Congress Management) to support planning and delivery of medical objectives based on unmet medical needs.Collaborate and communicate with US Commercialization & Access organizations to integrate medical perspectives into the commercialization process and ensure appropriate alignment between commercial and medical plans.Engage with external thought leaders and scientific experts to assess unmet medical needs to develop appropriate medical strategies.University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader.Application Instructions:
Do not click the “Apply Now” button to the right. We do not accept applications or schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at
http://pharmafellows.rutgers.edu .The RPIF Program application portal opens at 9 AM ET on October 11th.
Initial
interviews will be conducted on a rolling basis virtually (video conference) starting October 21st.
To apply, candidates MUST use the RPIF website (
http://pharmafellows.rutgers.edu/how-to-apply/
) to create a RPIF Candidate Account and upload the required application materials
by the dates noted below.
Remember that the application process is on a rolling basis, so earlier is better.
Please see our website for additional important recruitment information and dates.Initial offers will not be made until December 16th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers. Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status.Candidate Checklist:Create an RPIF Candidate Account starting now.Upload RPIF Application Materials to RPIF Candidate Account starting October 11, 2024.Applications are considered on a
rolling basis . The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and Curriculum Vitae (CV) by October 18, 2024.Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1, 2024.RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas.Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law.Other commitments can be found at the link below:https://uhr.rutgers.edu/prospective-employees/the-ru-commitment
#J-18808-Ljbffr
– Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and Bristol Myers Squibb. Program emphasis is in
WW & US Oncology Medical Strategy . This 2-year Fellowship provides a unique opportunity to support the development and execution of Worldwide and US Oncology Medical Strategy and other medical activities. During the first year in Worldwide Medical Oncology, the Fellow will focus on developing the global strategy for new indications in a wide array of tumor types through collaborative efforts with BMS regional offices around the world. During the second year in US Medical Oncology, the Fellow will focus on developing and executing the US strategy for the successful launch and continued support of a wide range of indications through medical engagements, conferences, and launches. The Fellow will gain exposure to various stakeholders and develop leadership skills by supporting and leading medical initiatives in collaboration with the Worldwide and US cross-functional matrix teams (e.g., Clinical Development, Clinical Operations, Regulatory, Publications and Scientific Content, Field Medical, Commercial, HEOR, Competitive Intelligence, Access and more). Additionally, the Fellow will have opportunities to collaborate closely with the patient advocacy team, including partnering to present and execute patient advocacy advisory boards, attending patient advocacy meetings at congresses, and developing various patient-related tactics. This will provide the Fellow with a deep understanding of how our work directly impacts patients’ lives.WORLDWIDE MEDICAL STRATEGYGain experience in the development of a strategically-aligned Global Medical Plan based upon unmet medical need by collaborating with a cross-functional, multi-regional (i.e., US, EU, Asia-Pacific) Worldwide Medical matrix team.Engage with external Thought Leaders in an effort to exchange and gather scientific and clinical knowledge through investigator meetings, advisory boards, Thought Leader Engagements (TLEs), publication planning, and congresses.Lead the execution of medical deliverables that are closely aligned with the strategic Global Medical Plan, including National and International Congress planning for activities such as advisory boards, symposia, and TLEs.Collaborate with BMS country-specific medical colleagues to collect field insights that will support strategic planning and tactical execution.Actively participate in the review and approval process of Investigator Sponsored Research proposals that are aligned with the data generation plan detailed in the Global Medical Plan.US MEDICAL STRATEGYParticipate in key medical activities such as medical advisory boards, Field Medical resources and trainings, Congress planning (e.g., ASCO, ASCO GI), reactive content, and the communication strategy, including publications.Collaborate with US Medical matrix teams (e.g., Field Medical, Evidence Generation, Patient Advocacy, Medical Education, and Congress Management) to support planning and delivery of medical objectives based on unmet medical needs.Collaborate and communicate with US Commercialization & Access organizations to integrate medical perspectives into the commercialization process and ensure appropriate alignment between commercial and medical plans.Engage with external thought leaders and scientific experts to assess unmet medical needs to develop appropriate medical strategies.University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader.Application Instructions:
Do not click the “Apply Now” button to the right. We do not accept applications or schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at
http://pharmafellows.rutgers.edu .The RPIF Program application portal opens at 9 AM ET on October 11th.
Initial
interviews will be conducted on a rolling basis virtually (video conference) starting October 21st.
To apply, candidates MUST use the RPIF website (
http://pharmafellows.rutgers.edu/how-to-apply/
) to create a RPIF Candidate Account and upload the required application materials
by the dates noted below.
Remember that the application process is on a rolling basis, so earlier is better.
Please see our website for additional important recruitment information and dates.Initial offers will not be made until December 16th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers. Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status.Candidate Checklist:Create an RPIF Candidate Account starting now.Upload RPIF Application Materials to RPIF Candidate Account starting October 11, 2024.Applications are considered on a
rolling basis . The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and Curriculum Vitae (CV) by October 18, 2024.Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1, 2024.RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas.Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law.Other commitments can be found at the link below:https://uhr.rutgers.edu/prospective-employees/the-ru-commitment
#J-18808-Ljbffr